Search

Your search keyword '"Jennings, Lisa"' showing total 3,458 results

Search Constraints

Start Over You searched for: Author "Jennings, Lisa" Remove constraint Author: "Jennings, Lisa"
3,458 results on '"Jennings, Lisa"'

Search Results

2. The Challenge of Integrating Social Justice Content into Social Work Education: Making the Abstract More Concrete

5. Pharmacodynamic Effects of Vorapaxar in Patients With and Without Diabetes Mellitus: Results of the OPTIMUS-5 Study

6. Switching from Dual Antiplatelet Therapy with Aspirin Plus a P2Y12 Inhibitor to Dual Pathway Inhibition with Aspirin Plus Vascular-Dose Rivaroxaban: The Switching Anti-Platelet and Anti-Coagulant Therapy (SWAP-AC) Study.

7. Effects of genetic variation in protease activated receptor 4 after an acute coronary syndrome: Analysis from the TRACER trial

8. Switching from dual antiplatelet therapy with aspirin plus a P2Y12 inhibitor to dual pathway inhibition with aspirin plus vascular-dose rivaroxaban

9. 1157 WITCHING FROM DUAL ANTIPLATELET THERAPY WITH ASPIRIN PLUS A P2Y12 INHIBITOR TO DUAL PATHWAY INHIBITION WITH ASPIRIN PLUS VASCULAR-DOSE RIVAROXABAN: THE SWITCHING ANTI-PLATELET AND ANTI-COAGULANT THERAPY (SWAP-AC) STUDY

11. Association of Aspirin Dose and Vorapaxar Safety and Efficacy in Patients With Non–ST-Segment Elevation Acute Coronary Syndrome (from the TRACER Trial)

13. BLURRED LINES: The boundaries are shifting as grocery stores and meal kits edge in on restaurants

14. Long-Term Care and Life Planning Preferences for Older Gays and Lesbians

15. Fast-casual pizza segment cools: national leaders emerge as the shakeout begins

18. Platelet P2Y12 inhibiting therapy in adjunct to vascular dose of rivaroxaban or aspirin: a pharmacodynamic study of dual pathway inhibition vs. dual antiplatelet therapy

20. Building a better bar: casual-dining chains renew focus on craft beers and fresh, seasonal cocktails

21. Bentracimab for Ticagrelor Reversal in Patients Undergoing Urgent Surgery

22. Pharmacodynamic Profiles of Dual-Pathway Inhibition with or without Clopidogrel versus Dual Antiplatelet Therapy in Patients with Atherosclerotic Disease

24. 10 Pharmacodynamic profiles of aspirin versus dual-pathway inhibition with either aspirin or clopidogrel among patients with stable atherosclerotic disease

27. 2014: the year in review

40. Supplement to: Thrombin-receptor antagonist vorapaxar in acute coronary syndromes.

41. Making connections: industry comes together to share strategies, celebrate leaders at annual MUFSO conference

43. Catch the consumer: map a new route to win guest traffic

44. Pleasing their palates

45. PHARMACODYNAMIC PROFILES OF DUAL ANTIPLATELET THERAPY VERSUS DUAL PATHWAY INHIBITION IN PATIENTS WITH ATHEROSCLEROTIC DISEASE MANIFESTATIONS

46. PHARMACODYNAMIC EFFECTS OF ADJUNCTIVE CLOPIDOGREL THERAPY IN PATIENTS WITH ATHEROSCLEROTIC DISEASE ON DUAL PATHWAY INHIBITION WITH ASPIRIN AND LOW-DOSE RIVAROXABAN

47. Platelets undergo phosphorylation of Syk at Y525/526 and Y352 in response to pathophysiological shear stress

48. DoorDash to pay $2.5 million to settle District of Columbia driver gratuity lawsuit

49. Thrombo-Inflammation in Cardiovascular Disease : An Expert Consensus Document from the Third Maastricht Consensus Conference on Thrombosis

50. Association between thrombolysis in myocardial infarction myocardial perfusion grade, biomarkers, and clinical outcomes among patients with moderate- to high-risk acute coronary syndromes: observations from the Randomized Trial to Evaluate the Relative PROTECTion against Post-PCI Microvascular Dysfunction and Post-PCI Ischemia among Antiplatelet and Antithrombotic Agents - Thrombolysis In Myocardial Infarction 30 (PROTECT-TIMI 30)

Catalog

Books, media, physical & digital resources